Sham TMS: Clinical Trials

51 trials of Sham TMS, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

25 completed, 13 recruiting, 5 not yet recruiting, 3 unknown. 40 Not applicable, 5 Phase 2, 3 Phase 3, 2 Early Phase 1, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable40Completed 19, Recruiting 10, Not yet recruiting 4, Enrolling by invitation 2, Terminated 2, Unknown 2, Withdrawn 1
Phase 25Completed 2, Recruiting 2, Unknown 1
Phase 33Completed 1, Not yet recruiting 1, Recruiting 1
Early Phase 12Completed 1, Recruiting 1
Phase 12Completed 1, Recruiting 1

Follow Sham TMS: new trials by email Literature Review of Sham TMS trials Research Report on Sham TMS

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Robotic Transcranial Magnetic Stimulation for Treatment Resistant Depression: The SPARC-TMS Trial
Neuronavigated robotic-enabled TMS, NRX-101, Sham TMS - Treatment Resistant Depression, Treatment Resistant Depression (TRD)
Phase 2 / Phase 3RecruitingNeuroRx, Inc.2402026-12-012026-10-21
Rapid Acceleration Process for Intensive Treatment of PTSD in 5 Days
Transcranial magnetic stimulation, Sham transcranial magnetic stimulation - PTSD
Phase 3Not yet recruitingVA Office of Research and Development902026-11-162026-10-05
Effect of cTBS on Startle and TMS-evoked BOLD
Active TMS, Sham TMS - Anxiety
Not applicableNot yet recruitingUniversity of Pennsylvania1402026-11-012026-10-14
Arousal-related Memory Following Theta Burst Stimulation.
Active TMS, Sham TMS - Anxiety
Not applicableNot yet recruitingUniversity of Pennsylvania1202026-10-012026-08-05
One-Day cTBS Over the Precuneus
Precuneus-targeted continuous theta-burst stimulation, Left dorsolateral prefrontal cortex intermittent theta-burst stimulation, Sham transcranial magnetic stimulation - Depressive Disorder, Treatment-Resistant, Treatment Resistant Depression (TRD)
Not applicableRecruitingMclean Hospital692026-09-082026-09-11
Fighting Fatigue in Multiple Sclerosis: TMS vs. tDCS Efficacy.
TMS, tDCS, Sham TMS - Multiple Sclerosis
Not applicableNot yet recruitingUniversitat Oberta de Catalunya802026-09-012026-09-25
Modulatory Effects of Personalized Transcranial Magnetic Stimulation (TMS) on Heart-Brain Coupling in Individuals With Depressive Tendencies
DLPFC-insula TMS, DLPFC-sgACC TMS, 10-20 F3 TMS - Depression Disorder, fMRI Research
Not applicableRecruitingXidian University602026-08-012026-08-07
The Effect of tDCS Combined With TMS on Cognitive Impairment and Motor Function After Stroke
occupational therapy, real tDCS, sham tDCS - Stroke, Cognition Disorders
Not applicableNot yet recruitingKe Dong, MD242026-05-012026-05-11
Mechanisms Of Orbitofrontal Stimulation in Depression
Sham TMS, Active TMS - Major Depressive Disorder (MDD)
Not applicableRecruitingSubha Subramanian802026-04-152026-05-14
Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression
D-Cycloserine (DCS), Continuous theta-burst stimulation (cTBS), Transcranial Magnetic Stimulation Sham - Major Depression
Early Phase 1RecruitingMclean Hospital802026-03-112026-05-13
Effect of TMS on Neuropathic Pain for Patients With Sci
active TMS, sham TMS - Spinal Cord Injury, Neuropathic Pain
Not applicableRecruitingAnkara Etlik City Hospital392025-12-152026-02-24
Brain Stimulation in Long COVID
Repetitive Transcranial Magnetic Stimulation, Sham device - Long COVID, PASC Post Acute Sequelae of COVID 19
Not applicableRecruitingAmsterdam UMC, location VUmc662025-11-172025-12-19
Evaluation of the Efficacy of Neuromodulation in the Control of Chronic Orofacial Pain
Active Neuromodulation (tDCS or TMS), Sham Neuromodulation (tDCS or TMS) - Orofacial Pain
Not applicableEnrolling by invitationEgas Moniz - Cooperativa de Ensino Superior, CRL502025-11-012026-02-20
Long Term Effect of Brain Stimulation in PPA
TMS, tDCS, Sham TMS - Primary Progressive Aphasia(PPA)
Not applicableRecruitingHospital San Carlos, Madrid802025-09-152026-04-23
Accelerated rTMS vs. Sham for Stroke Apathy
MagVenture MagPro Transcranial Magnetic Stimulation (TMS) System (Active), MagVenture MagPro Transcranial Magnetic Stimulation (TMS) System (Sham), Brainsight Neuronavigation System - Apathy, Stroke
Phase 1 / Phase 2RecruitingMedical University of South Carolina402025-08-082026-07-08
Transcranial Magnetic Stimulation for Methamphetamine Use Disorder in PLWH
intermittent theta burst stimulation (iTBS), continuous theta burst stimulation (cTBS), Sham TMS - Methamphetamine Use Disorders, HIV
Not applicableCompletedGopalkumar Rakesh122025-03-112026-08-06
Effects of Concurrent and Consecutive Repetitive Transcranial Magnetic Stimulation (rTMS) and Cognitive Bias Modification (CBM)
TMS, Cognitive Bias Modification, Sham TMS - Depression - Major Depressive Disorder
Not applicableRecruitingThe University of Hong Kong1802025-02-242026-10-16
The Effect of TPS on Cognitive Functions in Older Adults With MCI
transcranial pulse stimulation, Sham TMS - Mild Cognitive Impairment
Not applicableEnrolling by invitationThe University of Hong Kong1002024-10-022024-10-10
Testing an Accelerated TMS Protocol for Methamphetamine Use Disorder
Sham TMS, Active TMS - Methamphetamine Use Disorder
Not applicableRecruitingUniversity of Colorado, Denver202024-09-032025-10-03
rTMS as an Intervention for Levodopa-induced Dyskinesia
active TMS, sham TMS - Dyskinesia, Drug-Induced, Parkinson Disease
Not applicableRecruitingDanish Research Centre for Magnetic Resonance682024-08-222026-08-27

Showing 20 of 51. Sign in to see all of them.

Conditions studied

Depression (7)  ·  Depressive Disorder, Major (6)  ·  Parkinson Disease (3)  ·  Schizophrenia (3)  ·  Anxiety Disorders (2)  ·  Aphasia (2)  ·  Chronic Pain (2)  ·  Depressive Disorder, Treatment-Resistant (2)  ·  Opioid-Related Disorders (2)  ·  Stress Disorders, Post-Traumatic (2)  ·  Stroke (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Acrophobia (1)  ·  Alzheimer Disease (1)  ·  Aphasia, Primary Progressive (1)

Sponsors

University of Pennsylvania (5)  ·  Gopalkumar Rakesh (3)  ·  Mclean Hospital (3)  ·  University of Colorado, Denver (3)  ·  VA Office of Research and Development (3)  ·  Bayside Health (2)  ·  Medical University of South Carolina (2)  ·  The University of Hong Kong (2)  ·  Amsterdam UMC, location VUmc (1)  ·  Ankara Etlik City Hospital (1)  ·  BeerYaakov Mental Health Center (1)  ·  Beth Israel Deaconess Medical Center (1)  ·  Centre Hospitalier St Anne (1)  ·  Changping Laboratory (1)  ·  Danish Research Centre for Magnetic Resonance (1)

Countries

United States (28)  ·  Australia (3)  ·  China (3)  ·  Canada (2)  ·  Hong Kong (2)  ·  Turkey (Türkiye) (2)  ·  Brazil (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Israel (1)  ·  Netherlands (1)  ·  Portugal (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

H. Branch Coslett, MD (3)  ·  Aimee L. Mcrae-Clark, PharmD (1)  ·  Ann K Shinn, MD, MPH (1)  ·  Benzi Kluger, MD (1)  ·  Benzi M Kluger, MD, MS (1)  ·  Bianca B. Bellini (1)  ·  Bradley V Watts, MD MPH (1)  ·  Carlos A Zarate, M.D. (1)  ·  Christine Conelea, PhD (1)  ·  Craig Rush, PhD (1)  ·  Edward B Short, MD (1)  ·  Emine O Bayman (1)

Results publications

PMID 37693107, PMID 16136173, PMID 21764215, PMID 25038985, PMID 28496402, PMID 28686990, PMID 29153927, PMID 30122975, PMID 30503621, PMID 31415654, PMID 32839957, PMID 33045706, PMID 34062145, PMID 37716637, PMID 37839775, PMID 38025437, PMID 38956966, PMID 39440449, PMID 42161537

NIH funding

R01DC016800 (2), K01DA043652 (1), K02NS080885 (1), K24DA058882 (1), P30CA177558 (1), R01MH139697 (1), UL1TR001998 (1)